185 related articles for article (PubMed ID: 22020975)
1. The role of mRNA decay in p53-induced gene expression.
Melanson BD; Bose R; Hamill JD; Marcellus KA; Pan EF; McKay BC
RNA; 2011 Dec; 17(12):2222-34. PubMed ID: 22020975
[TBL] [Abstract][Full Text] [Related]
2. The p53 protein induces stable miRNAs that have the potential to modify subsequent p53 responses.
Cabrita MA; Bose R; Vanzyl EJ; Pastic A; Marcellus KA; Pan E; Hamill JD; McKay BC
Gene; 2017 Apr; 608():86-94. PubMed ID: 28119089
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells.
Lee JE; Lee JY; Wilusz J; Tian B; Wilusz CJ
PLoS One; 2010 Jun; 5(6):e11201. PubMed ID: 20574513
[TBL] [Abstract][Full Text] [Related]
4. RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability.
Yin T; Cho SJ; Chen X
J Biol Chem; 2013 Aug; 288(33):23680-6. PubMed ID: 23836903
[TBL] [Abstract][Full Text] [Related]
5. Tuning of mRNA stability through altering 3'-UTR sequences generates distinct output expression in a synthetic circuit driven by p53 oscillations.
Koh WS; Porter JR; Batchelor E
Sci Rep; 2019 Apr; 9(1):5976. PubMed ID: 30979970
[TBL] [Abstract][Full Text] [Related]
6. The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element.
Vilborg A; Glahder JA; Wilhelm MT; Bersani C; Corcoran M; Mahmoudi S; Rosenstierne M; Grandér D; Farnebo M; Norrild B; Wiman KG
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15756-61. PubMed ID: 19805223
[TBL] [Abstract][Full Text] [Related]
7. Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways.
Barbier J; Dutertre M; Bittencourt D; Sanchez G; Gratadou L; de la Grange P; Auboeuf D
Mol Cell Biol; 2007 Oct; 27(20):7315-33. PubMed ID: 17709397
[TBL] [Abstract][Full Text] [Related]
8. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay.
Rattenbacher B; Beisang D; Wiesner DL; Jeschke JC; von Hohenberg M; St Louis-Vlasova IA; Bohjanen PR
Mol Cell Biol; 2010 Aug; 30(16):3970-80. PubMed ID: 20547756
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tumor suppressor p53 at the RNA level.
Vilborg A; Wilhelm MT; Wiman KG
J Mol Med (Berl); 2010 Jul; 88(7):645-52. PubMed ID: 20306257
[TBL] [Abstract][Full Text] [Related]
10. Short-lived AUF1 p42-binding mRNAs of RANKL and BCL6 have two distinct instability elements each.
Dogar AM; Pauchard-Batschulat R; Grisoni-Neupert B; Richman L; Paillusson A; Pradervand S; Hagenbüchle O; Ambrosini G; Schmid CD; Bucher P; Kühn LC
PLoS One; 2018; 13(11):e0206823. PubMed ID: 30418981
[TBL] [Abstract][Full Text] [Related]
11. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative feedback loops in the p53 and mRNA 3' processing pathways.
Devany E; Zhang X; Park JY; Tian B; Kleiman FE
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3351-6. PubMed ID: 23401530
[TBL] [Abstract][Full Text] [Related]
13. MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.
Xu E; Zhang J; Chen X
Oncogene; 2013 Apr; 32(17):2169-78. PubMed ID: 22710720
[TBL] [Abstract][Full Text] [Related]
14. Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells.
Galbán S; Martindale JL; Mazan-Mamczarz K; López de Silanes I; Fan J; Wang W; Decker J; Gorospe M
Mol Cell Biol; 2003 Oct; 23(20):7083-95. PubMed ID: 14517280
[TBL] [Abstract][Full Text] [Related]
15. 5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage.
Chen J; Kastan MB
Genes Dev; 2010 Oct; 24(19):2146-56. PubMed ID: 20837656
[TBL] [Abstract][Full Text] [Related]
16. Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover.
Shetty P; Velusamy T; Bhandary YP; Shetty RS; Liu MC; Shetty S
Am J Respir Cell Mol Biol; 2008 Sep; 39(3):364-72. PubMed ID: 18390474
[TBL] [Abstract][Full Text] [Related]
17. DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms.
Hsing A; Faller DV; Vaziri C
J Biol Chem; 2000 Aug; 275(34):26024-31. PubMed ID: 10856296
[TBL] [Abstract][Full Text] [Related]
18. Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.
Shetty S; Shetty P; Idell S; Velusamy T; Bhandary YP; Shetty RS
J Biol Chem; 2008 Jul; 283(28):19570-80. PubMed ID: 18469003
[TBL] [Abstract][Full Text] [Related]
19. mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.
Bolognani F; Gallani AI; Sokol L; Baskin DS; Meisner-Kober N
J Neurooncol; 2012 Feb; 106(3):531-42. PubMed ID: 21935689
[TBL] [Abstract][Full Text] [Related]
20. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.
Rossi M; Demidov ON; Anderson CW; Appella E; Mazur SJ
Nucleic Acids Res; 2008 Dec; 36(22):7168-80. PubMed ID: 19015127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
